Lippman Evan
Officer, EVP BUSINESS DEVELOPMENT at TEVA
- Sold, on record
- $2.2M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Aug 17, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TEVATEVA PHARMACEUTICAL INDUSTRIES LTDOfficer, EVP BUSINESS DEVELOPMENT
Sales by reason
2
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice TEVANoticeMay 14, 2026 2026
Filed to sell 41,658 shares ($1.5M)
Lippman Evan, Officer, EXECUTIVE VP BUSINESS DEVELOPMENT
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale TEVARoutineMay 14, 2026 same day
Sold 41,658 shares at $35.58 ($1.5M)
Lippman Evan, EVP, Business Development
10b5-1 planSold 48.5% of holdings ($3.1M position)44,191 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice TEVANoticeAug 17, 2026 +95 days
Filed to sell 18,600 shares ($680k)
Lippman Evan, Officer, EVP BUSINESS DEVELOPMENT
10b5-1 planFiling
- 4 Form 4 sale TEVARoutineAug 17, 2026 same day
Sold 18,600 shares at $36.57 ($680k)
Lippman Evan, EVP, Business Development
10b5-1 planSold 42.1% of holdings ($1.6M position)25,591 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Aug 19, 2026 | TEVA | EVP, Business Development | Form 4 sale | 18,600 | $680k | 42.1% | Routine | SEC |
| Aug 17, 2026 | Aug 17, 2026 | TEVA | Officer, EVP BUSINESS DEVELOPMENT | Form 144 notice | 18,600 | $680k | Notice | SEC | |
| May 14, 2026 | May 18, 2026 | TEVA | EVP, Business Development | Form 4 sale | 41,658 | $1.5M | 48.5% | Routine | SEC |
| May 14, 2026 | May 14, 2026 | TEVA | Officer, EXECUTIVE VP BUSINESS DEVELOPMENT | Form 144 notice | 41,658 | $1.5M | Notice | SEC |